“The treatment for metastatic prostate cancer has dramatically improved over the past 10 years,” says Dr. David Wise, a medical oncologist at NYU Perlmutter Cancer Center. The standard of care is androgen deprivation therapy. However, Dr. Wise says newer medications like abiraterone (Zytiga) are being added to boost the effect and delay the cancer from progressing.
Fact Checked
/ Updated January 3rd, 2022SurvivorNet Fact Checking and Medical Review Standards:
The SurvivorNet News Team creates high quality medical information that complies with our industry leading standards for factual accuracy and sourcing from leading experts at academic medical institutions. Every news article is thoroughly fact-checked by our physician collaborators. We vet each piece of work for factual integrity, impartiality, and clearly label any professional conflicts.
All SurvivorNet articles adhere to the following standards:
- All studies and research papers cited are from reputable academic medical institutions or peer-reviewed journals.
- When we use data, statistics, or quotes these references link to the original source.
- All content related to new treatments, drugs, procedures, and so on must clearly describe availability, side effects, treatment target (such as triple negative breast cancer)
- All medical information on SurvivorNet is sourced from respected medical professionals with verified medical credentials and links are provided to these sources.
- We strive to give the reader relevant background information and include, clearly-sourced contextual health information in all articles. Readers are clearly alerted to any conflicts of interest from a medical source or the authors of a cited study.
Metastatic Prostate Cancer Treatment is Improving
The Drug Anktiva Plus BCG for Early-Stage Bladder Cancer Treatment Offers A Good Non-Surgical Option
Treatment Options For Early Endometrial Cancer and Beyond
News Anchor Taking Leave of Absence for Prostate Cancer Surgery
Given Months To Live, Entertainment Tonight Host John Tesh, 71, Beat Cancer & Defied The Odds
Rybrevant: A New Drug For Hard-To-Treat Non-Small Cell Lung Cancer
A Tailored Approach to Liver Cancer Treatment